News

Posted On: 01/10/2007

Management Joins with Investor Group to Leverage Novasep Buyout

PharmaManufacturing.com

Groupe Novasep has been acquired for an enterprise value of EUR 425 million by its management and a financial investor group composed of Gilde Buy Out, Banexi Capital Partenaires and BNP Paribas effective Jan. 9.

Groupe Novasep, with its headquarters in Pompey, near Nancy in eastern France, operates mainly in Europe, with subsidiaries in the United States, China and Japan, and has 1,300 employees working in nine sites. It will continue to operate through two complementary divisions: Novasep Synthesis and Novasep Process.

Novasep Synthesis provides R&D and offers custom synthesis services utilizing niche technologies to produce elaborate molecules for the pharmaceutical industry, as well as producing and marketing proprietary products, typically generics.

Novasep Process offers laboratory purification equipment and large-scale industrial production plants for producing pure products, and a full range of services including process development, multi-ton scale custom purification, chromatography and performance optimization for the pharmaceutical, biopharmaceutical and industrial biotech markets.

To learn more about Groupe Novasep, visit www.novasep.com.